tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Stock Forecast & Price Target

Compare
278 Followers
See the Price Targets and Ratings of:

REVB Financial Forecast

REVB Earnings Forecast

Next quarter’s earnings estimate for REVB is -$0.33 with a range of -$0.33 to -$0.33. The previous quarter’s EPS was -$1.77. REVB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year REVB has Performed in-line its overall industry.
Next quarter’s earnings estimate for REVB is -$0.33 with a range of -$0.33 to -$0.33. The previous quarter’s EPS was -$1.77. REVB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year REVB has Performed in-line its overall industry.
No data currently available

REVB Sales Forecast

Next quarter’s sales forecast for REVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. REVB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year REVB has Performed in-line its overall industry.
Next quarter’s sales forecast for REVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. REVB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year REVB has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM
$20
Buy
2225.58%
Upside
Reiterated
09/16/25
Revelation Biosciences (REVB) Gets a Buy from Roth MKM
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM
$20
Buy
2225.58%
Upside
Reiterated
09/16/25
Revelation Biosciences (REVB) Gets a Buy from Roth MKM
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Revelation Biosciences

1 Month
xxx
Success Rate
2/10 ratings generated profit
20%
Average Return
-10.03%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -10.03% per trade.
3 Months
xxx
Success Rate
0/10 ratings generated profit
0%
Average Return
-51.53%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -51.53% per trade.
1 Year
Success Rate
0/10 ratings generated profit
0%
Average Return
-86.81%
reiterated a buy rating 3 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.81% per trade.
2 Years
xxx
Success Rate
0/10 ratings generated profit
0%
Average Return
-89.08%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -89.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

REVB Analyst Recommendation Trends

Rating
Jan 25
Mar 25
Apr 25
Aug 25
Sep 25
Strong Buy
0
1
1
2
2
Buy
1
1
0
0
0
Hold
0
0
0
0
0
Sell
8
9
9
5
3
Strong Sell
0
0
0
0
0
total
9
11
10
7
5
In the current month, REVB has received 2 Buy Ratings, 0 Hold Ratings, and 3 Sell Ratings. REVB average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

REVB Stock Forecast FAQ

What is REVB’s average 12-month price target, according to analysts?
Currently, no data Available
What is REVB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for REVB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is REVB a Buy, Sell or Hold?
      Revelation Biosciences has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Revelation Biosciences’s price target?
        Currently, no data Available
        What do analysts say about Revelation Biosciences?
        Revelation Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of REVB?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.